Skip to main content

Table 6 Summary of lymphocyte profile values at screening, 1 month & 6 month follow-up after BM-MSC implantation

From: A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

Test

Screening

1 month

6 months

BM-MSC arm

Placebo

BM-MSC arm

Placebo

BM-MSC arm

Placebo

N = 10

N = 10

N = 9

N = 10

N = 7

N = 10

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

CD4 (cells/μl)

923.1 (217.52)

856.3 (237.29)

905.6 (134.37)

922.4 (451.48)

1020.9 (405.67)

954.4 (164.49)

CD8 (cells/μl)

682.5 (253.96)

688.3 (420.36)

664.2 (183.02)

644.9 (396.27)

786.3 (329.27)

727.9 (312.25)

CD25 (cells/μl)

21.3 (22.22)

16.3 (10.92)

21.7 (14.34)

22.0 (20.66)

30.3 (25.36)

35.3 (28.04)